INTRODUCTION: Mutations in GJB2 are the most common cause of non-syndromic autosomal recessive hearing impairment, ranging from mild to profound. Mutation analysis of this gene is widely available as a genetic diagnostic test. OBJECTIVE: To assess a possible genotype-phenotype correlation for GJB2. DESIGN: Retrospective analysis of audiometric data from people with hearing impairment, segregating two GJB2 mutations. SUBJECTS: Two hundred and seventy seven unrelated patients with hearing impairment who were seen at the ENT departments of local and university hospitals from Italy, Belgium, Spain, and the United States, and who harboured bi-allelic GJB2 mutations. RESULTS: We found that 35delG homozygotes have significantly more hearing impairment, compared with 35delG/non-35delG compound heterozygotes. People with two non-35delG mutations have even less hearing impairment. We observed a similar gradient of hearing impairment when we categorised mutations as inactivating (that is, stop mutations or frame shifts) or non-inactivating (that is, missense mutations). We demonstrated that certain mutation combinations (including the combination of 35delG with the missense mutations L90P, V37I, or the splice-site mutation IVS1+1G>A, and the V37I/V37I genotype) are associated with significantly less hearing impairment compared with 35delG homozygous genotypes. CONCLUSIONS: This study is the first large systematic analysis indicating that the GJB2 genotype has a major impact on the degree of hearing impairment, and identifying mild genotypes. Furthermore, this study shows that it will be possible to refine this correlation and extend it to additional genotypes. These data will be useful in evaluating habilitation options for people with GJB2 related deafness.
INTRODUCTION: Mutations in GJB2 are the most common cause of non-syndromic autosomal recessive hearing impairment, ranging from mild to profound. Mutation analysis of this gene is widely available as a genetic diagnostic test. OBJECTIVE: To assess a possible genotype-phenotype correlation for GJB2. DESIGN: Retrospective analysis of audiometric data from people with hearing impairment, segregating two GJB2 mutations. SUBJECTS: Two hundred and seventy seven unrelated patients with hearing impairment who were seen at the ENT departments of local and university hospitals from Italy, Belgium, Spain, and the United States, and who harboured bi-allelic GJB2 mutations. RESULTS: We found that 35delG homozygotes have significantly more hearing impairment, compared with 35delG/non-35delG compound heterozygotes. People with two non-35delG mutations have even less hearing impairment. We observed a similar gradient of hearing impairment when we categorised mutations as inactivating (that is, stop mutations or frame shifts) or non-inactivating (that is, missense mutations). We demonstrated that certain mutation combinations (including the combination of 35delG with the missense mutations L90P, V37I, or the splice-site mutation IVS1+1G>A, and the V37I/V37I genotype) are associated with significantly less hearing impairment compared with 35delG homozygous genotypes. CONCLUSIONS: This study is the first large systematic analysis indicating that the GJB2 genotype has a major impact on the degree of hearing impairment, and identifying mild genotypes. Furthermore, this study shows that it will be possible to refine this correlation and extend it to additional genotypes. These data will be useful in evaluating habilitation options for people with GJB2 related deafness.
Authors: P J Govaerts; M Yperman; G De Ceulaer; K Daemers; K Van Driessche; T Somers; F E Offeciers Journal: Otol Neurotol Date: 2001-11 Impact factor: 2.311
Authors: L Morlé; M Bozon; N Alloisio; P Latour; A Vandenberghe; H Plauchu; L Collet; P Edery; J Godet; G Lina-Granade Journal: J Med Genet Date: 2000-05 Impact factor: 6.318
Authors: J Löffler; D Nekahm; A Hirst-Stadlmann; B Günther; H J Menzel; G Utermann; A R Janecke Journal: Eur J Hum Genet Date: 2001-03 Impact factor: 4.246
Authors: L Van Laer; P Coucke; R F Mueller; G Caethoven; K Flothmann; S D Prasad; G P Chamberlin; M Houseman; G R Taylor; C M Van de Heyning; E Fransen; J Rowland; R A Cucci; R J Smith; G Van Camp Journal: J Med Genet Date: 2001-08 Impact factor: 6.318
Authors: P Gasparini; R Rabionet; G Barbujani; S Melçhionda; M Petersen; K Brøndum-Nielsen; A Metspalu; E Oitmaa; M Pisano; P Fortina; L Zelante; X Estivill Journal: Eur J Hum Genet Date: 2000-01 Impact factor: 4.246
Authors: X Estivill; P Fortina; S Surrey; R Rabionet; S Melchionda; L D'Agruma; E Mansfield; E Rappaport; N Govea; M Milà; L Zelante; P Gasparini Journal: Lancet Date: 1998-02-07 Impact factor: 79.321
Authors: Qianqian Zhu; Dongliang Ge; Erin L Heinzen; Samuel P Dickson; Thomas J Urban; Mingfu Zhu; Jessica M Maia; Min He; Qian Zhao; Kevin V Shianna; David B Goldstein Journal: Am J Hum Genet Date: 2012-08-30 Impact factor: 11.025
Authors: Kenneth H Lee; Daniel A Larson; Gordon Shott; Brian Rasmussen; Aliza P Cohen; Corning Benton; Mark Halsted; Daniel Choo; Jareen Meinzen-Derr; John H Greinwald Journal: Laryngoscope Date: 2009-03 Impact factor: 3.325
Authors: Zubair M Ahmed; Xiaoyan Cindy Li; Shontell D Powell; Saima Riazuddin; Terry-Lynn Young; Khushnooda Ramzan; Zahoor Ahmad; Sandra Luscombe; Kiran Dhillon; Linda MacLaren; Barbara Ploplis; Lawrence I Shotland; Elizabeth Ives; Sheikh Riazuddin; Thomas B Friedman; Robert J Morell; Edward R Wilcox Journal: BMC Med Genet Date: 2004-09-24 Impact factor: 2.103
Authors: Prachi Kothiyal; Stephanie Cox; Jonathan Ebert; Ammar Husami; Margaret A Kenna; John H Greinwald; Bruce J Aronow; Heidi L Rehm Journal: BMC Biotechnol Date: 2010-02-10 Impact factor: 2.563